Harbor Capital Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8K Buy
317
+80
+34% +$1.89K ﹤0.01% 1046
2025
Q4
$6K Sell
237
-4
-2% -$106 ﹤0.01% 1114
2025
Q3
$7K Buy
+241
New +$6.53K ﹤0.01% 1085

Other funds holding ASTH

Harbor Capital Advisors's ASTH Position: Q1 2026 in Review

Harbor Capital Advisors increased its Astrana Health (ASTH) stake by 34% in Q1 2026, buying an estimated $1.89K and bringing the position to 317 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Harbor Capital Advisors first reported a position in ASTH in Q3 2025 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Harbor Capital Advisors held 317 shares of Astrana Health worth $8K as of Q1 2026.
  • Harbor Capital Advisors bought 80 Astrana Health shares in Q1 2026, an estimated $1.89K.
  • Astrana Health made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #1046 holding.
  • Harbor Capital Advisors first reported a position in Astrana Health in Q3 2025 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.